Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
7453 | 1365 | 27.8 | 61% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
275 | 3 | NSAIDS//CYCLOOXYGENASE//CYCLOOXYGENASE 2 | 43399 |
466 | 2 | NSAIDS//NON STEROIDAL ANTI INFLAMMATORY DRUGS//COX 2 INHIBITORS | 15930 |
7453 | 1 | CHIRAL INVERSION//DEXIBUPROFEN//IBUPROFEN | 1365 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | CHIRAL INVERSION | authKW | 393864 | 3% | 46% | 38 |
2 | DEXIBUPROFEN | authKW | 223666 | 1% | 50% | 20 |
3 | IBUPROFEN | authKW | 176264 | 10% | 6% | 142 |
4 | 2 ARYLPROPIONIC ACIDS | authKW | 173509 | 1% | 48% | 16 |
5 | KETOPROFEN | authKW | 151083 | 6% | 9% | 77 |
6 | FLOBUFEN | authKW | 137006 | 1% | 88% | 7 |
7 | R IBUPROFEN | authKW | 130140 | 1% | 73% | 8 |
8 | CHIRAL EXCIPIENT | authKW | 115037 | 0% | 86% | 6 |
9 | STEREOSELECTIVE DISSOLUTION | authKW | 111843 | 0% | 100% | 5 |
10 | KETOPROFEN ENANTIOMERS | authKW | 109602 | 1% | 70% | 7 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 15297 | 61% | 0% | 833 |
2 | Chemistry, Analytical | 5290 | 27% | 0% | 373 |
3 | Chemistry, Medicinal | 3010 | 14% | 0% | 197 |
4 | Biochemical Research Methods | 706 | 8% | 0% | 115 |
5 | Rheumatology | 355 | 3% | 0% | 44 |
6 | Chemistry, Multidisciplinary | 255 | 12% | 0% | 160 |
7 | Veterinary Sciences | 194 | 5% | 0% | 72 |
8 | Chemistry, Organic | 178 | 7% | 0% | 93 |
9 | Toxicology | 64 | 3% | 0% | 39 |
10 | Medicine, General & Internal | 21 | 4% | 0% | 50 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MICROBIAL BIOTRANSFORMAT GRP | 67106 | 0% | 100% | 3 |
2 | STN PERPETUA | 44737 | 0% | 100% | 2 |
3 | UNIDAD ESTUDIOS FARMACOL CLIN | 29823 | 0% | 67% | 2 |
4 | 5297 KUMEGAWA CHO | 22369 | 0% | 100% | 1 |
5 | ANALYT CHEM ETILER | 22369 | 0% | 100% | 1 |
6 | ANAT PHARAMCOL FORENS MED | 22369 | 0% | 100% | 1 |
7 | BAHAGIAN TEKNOL PERUBATAN | 22369 | 0% | 100% | 1 |
8 | BIO PHARMACEUT PHARMACOKINET | 22369 | 0% | 100% | 1 |
9 | BIOANALYSIS METAB PHARMACOKINET S | 22369 | 0% | 100% | 1 |
10 | BIOGENESIS NAT CPDS BIOTECHNOL | 22369 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CHIRALITY | 44585 | 6% | 3% | 78 |
2 | JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS | 9938 | 3% | 1% | 40 |
3 | JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS | 7975 | 2% | 1% | 29 |
4 | JOURNAL OF CLINICAL PHARMACOLOGY | 6538 | 3% | 1% | 40 |
5 | EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS | 5790 | 1% | 1% | 20 |
6 | BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 5525 | 3% | 1% | 45 |
7 | JOURNAL OF PHARMACEUTICAL SCIENCES | 5331 | 4% | 0% | 52 |
8 | EUROPEAN JOURNAL OF RHEUMATOLOGY AND INFLAMMATION | 5021 | 0% | 4% | 6 |
9 | CLINICAL PHARMACOKINETICS | 4156 | 2% | 1% | 21 |
10 | EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 4049 | 3% | 1% | 36 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CHIRAL INVERSION | 393864 | 3% | 46% | 38 | Search CHIRAL+INVERSION | Search CHIRAL+INVERSION |
2 | DEXIBUPROFEN | 223666 | 1% | 50% | 20 | Search DEXIBUPROFEN | Search DEXIBUPROFEN |
3 | IBUPROFEN | 176264 | 10% | 6% | 142 | Search IBUPROFEN | Search IBUPROFEN |
4 | 2 ARYLPROPIONIC ACIDS | 173509 | 1% | 48% | 16 | Search 2+ARYLPROPIONIC+ACIDS | Search 2+ARYLPROPIONIC+ACIDS |
5 | KETOPROFEN | 151083 | 6% | 9% | 77 | Search KETOPROFEN | Search KETOPROFEN |
6 | FLOBUFEN | 137006 | 1% | 88% | 7 | Search FLOBUFEN | Search FLOBUFEN |
7 | R IBUPROFEN | 130140 | 1% | 73% | 8 | Search R+IBUPROFEN | Search R+IBUPROFEN |
8 | CHIRAL EXCIPIENT | 115037 | 0% | 86% | 6 | Search CHIRAL+EXCIPIENT | Search CHIRAL+EXCIPIENT |
9 | STEREOSELECTIVE DISSOLUTION | 111843 | 0% | 100% | 5 | Search STEREOSELECTIVE+DISSOLUTION | Search STEREOSELECTIVE+DISSOLUTION |
10 | KETOPROFEN ENANTIOMERS | 109602 | 1% | 70% | 7 | Search KETOPROFEN+ENANTIOMERS | Search KETOPROFEN+ENANTIOMERS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | DAVIES, NM , (1998) CLINICAL PHARMACOKINETICS OF IBUPROFEN - THE FIRST 30 YEARS.CLINICAL PHARMACOKINETICS. VOL. 34. ISSUE 2. P. 101 -154 | 155 | 60% | 168 |
2 | WSOL, V , SKALOVA, L , SZOTAKOVA, B , (2004) CHIRAL INVERSION OF DRUGS: COINCIDENCE OR PRINCIPLE?.CURRENT DRUG METABOLISM. VOL. 5. ISSUE 6. P. 517-533 | 107 | 64% | 43 |
3 | BARBANOJ, MJ , ANTONIJOAN, RM , GICH, I , (2001) CLINICAL PHARMACOKINETICS OF DEXKETOPROFEN.CLINICAL PHARMACOKINETICS. VOL. 40. ISSUE 4. P. 245 -262 | 68 | 81% | 52 |
4 | TAN, SC , PATEL, BK , JACKSON, SHD , SWIFT, CG , HUTT, AJ , (2002) STEREOSELECTIVITY OF IBUPROFEN METABOLISM AND PHARMACOKINETICS FOLLOWING THE ADMINISTRATION OF THE RACEMATE TO HEALTHY VOLUNTEERS.XENOBIOTICA. VOL. 32. ISSUE 8. P. 683 -697 | 42 | 95% | 45 |
5 | EVANS, AM , (1992) ENANTIOSELECTIVE PHARMACODYNAMICS AND PHARMACOKINETICS OF CHIRAL NONSTEROIDAL ANTIINFLAMMATORY DRUGS.EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. VOL. 42. ISSUE 3. P. 237-256 | 69 | 66% | 168 |
6 | LANDONI, MF , SORACI, A , (2001) PHARMACOLOGY OF CHIRAL COMPOUNDS: 2-ARYLPROPIONIC ACID DERIVATIVES.CURRENT DRUG METABOLISM. VOL. 2. ISSUE 1. P. 37 -51 | 52 | 70% | 55 |
7 | MUSTONEN, K , NIEMI, A , RAEKALLIO, M , HEINONEN, M , PELTONIEMI, OAT , PALVIAINEN, M , SIVEN, M , PELTONIEMI, M , VAINIO, O , (2012) ENANTIOSPECIFIC KETOPROFEN CONCENTRATIONS IN PLASMA AFTER ORAL AND INTRAMUSCULAR ADMINISTRATION IN GROWING PIGS.ACTA VETERINARIA SCANDINAVICA. VOL. 54. ISSUE . P. - | 32 | 86% | 4 |
8 | SHARMA, P , GUTTIKAR, S , SOLANKI, G , PATEL, DP , SHRIVASTAV, PS , (2012) DETERMINATION OF (S)-(+)- AND (R)-(-)-IBUPROFEN ENANTIOMERS IN HUMAN PLASMA AFTER CHIRAL PRECOLUMN DERIVATIZATION BY REVERSED-PHASE LC-ESI-MS/MS.BIOANALYSIS. VOL. 4. ISSUE 24. P. 2909-2927 | 29 | 88% | 5 |
9 | HAO, HP , WANG, GJ , SUN, JG , (2005) ENANTIOSELECTIVE PHARMACOKINETICS OF IBUPROFEN AND INVOLVED MECHANISMS.DRUG METABOLISM REVIEWS. VOL. 37. ISSUE 1. P. 215 -234 | 51 | 57% | 42 |
10 | MULLANGI, R , YAO, M , SRINIVAS, NR , (2003) RESOLUTION OF ENANTIOMERS OF KETOPROFEN BY HPLC: A REVIEW.BIOMEDICAL CHROMATOGRAPHY. VOL. 17. ISSUE 7. P. 423 -434 | 38 | 83% | 22 |
Classes with closest relation at Level 1 |